Tools
Stock profile

INTEGRA LIFESCIENCES HOLDINGS CORP (IART)

IART · Latest close $13.86 as of Nov 18, 2026 · 13F data as of Jun 30, 2026 (2026 Q2)
Latest close
$13.86
As of Nov 18, 2026
Tracked funds holding
1 of 149
2026 Q2 13F filings
Opened / added
0 / 0
vs previous quarter
Trimmed / exited
1
vs previous quarter

INTEGRA LIFESCIENCES HOLDINGS CORP (IART) is held by 1 of 149 tracked super-investor funds (144 filed in Q2) in 2026 Q2 13F filings, with 1 fund trimming or exiting versus the previous quarter. Latest close $13.86 as of Nov 18, 2026.

Data as of Nov 18, 2026 (prices) · 2026 Q2 13F filings (quarter ended Jun 30, 2026) · Latest Form 4: none in the last 90 days · Congress to Nov 16, 2026.

Funds
2026 Q2 13F
Fundamentals
Revenue · FY2025
Red flags
none flagged
Short interest
as of Oct 15, 2026
Holdings · Charts · All institutions · Fundamentals · Short interest · Insider trading · 5% holders · Politician trading · Government relations · Screens & lenses · Signal record · Related stocks · Recent 8-K

Funds holding this

Rubric Capital Management — 1 tracked fund hold IART. See all holders.

Insider and Congress activity

No insider open-market activity or Congress trades reported for this stock in the recent window. Insider trading · Politician trading.

Often held alongside

No closely related stocks by co-holding for this stock. Browse all stocks.

Super-investor holdings · 2026 Q2

FundPortfolio weightSharesChange vs prev. quarter
Rubric Capital Management1.28%7,753,934HELD Q3 filed Nov 16
Maverick Capital——EXITED

Source: SEC Form 13F filings, quarter ended Jun 30, 2026. Change labels compare each fund’s 2026 Q2 filing with its previous filing. Fund counts aggregate every share class mapped to this ticker.

Price change since quarter-end: -24.3% from the close on the first trading day after the quarter ended (Jul 1, 2026) to the latest close (Nov 17, 2026). 13F does not report purchase prices — this is the price change since the quarter-end close, not a gain on any fund’s actual purchase.

Filing season: the Q3 2026 13F tracker follows every tracked fund’s filing for the quarter ended Sep 30, 2026, with its biggest buys and sells.

Charts

26.558.192024-11-192026-11-18

Closing prices (unadjusted for dividends), last 2 years — 501 trading days to Nov 18, 2026. Dashed lines mark 13F filing deadlines. Source: Yahoo Finance daily bars.

All institutions · Form 13F

Institutions holding211 of 8,857 filers
Long-only filers among them211
Change vs 2026 Q1+18 net · 208 entered · 190 exited
Shares reported, all filers73,288,672
Reported value, all filers$1.3B

Source: SEC Form 13F data sets — every filer's latest report for the quarter ended Jun 30, 2026, not just the tracked funds above; changes compare with the quarter ended Mar 31, 2026. Share counts and values are summed as reported in the filings (a small number of filers report values in thousands of dollars, so value totals are as-filed sums).

Company fundamentals

ExchangeNasdaq
IndustrySurgical & Medical Instruments & Apparatus (SIC 3841)
Revenue · FY2025$1.6B
Net income · FY2025$-516.5M
Total assets · FY2025$3.6B
Shares outstanding77,800,976
Market cap (at latest close)$1.1B

Source: SEC EDGAR company filings (submissions and company facts), collected Oct 30, 2026. Shares outstanding as reported Oct 22, 2026.

Short interest

Shares short · Oct 15, 20267,316,999
Share of shares outstanding9.40%
Days to cover5.52

Shares short at recent settlements — Jul 31, 2026: 6.5M · Aug 14, 2026: 6.7M · Aug 31, 2026: 6.9M · Sep 15, 2026: 6.8M · Sep 30, 2026: 7.3M · Oct 15, 2026: 7.3M.

Source: FINRA Equity Short Interest (biweekly settlement data). Shares outstanding from SEC filings as of Oct 22, 2026.

Insider trading · Form 4

Data unavailable — no Form 4 transactions for this ticker were parsed in the last 90 days.

5% holders · Schedule 13D/G

FiledFilerFormShares% ownedEvent dateSource
Aug 13, 2026PARADIGM CAPITAL MANAGEMENT INC/NYSC 13G/A——Mar 31, 2026SEC filing
Jul 31, 2026Vanguard Portfolio ManagementSC 13G3,912,8165.0%Jun 30, 2026SEC filing
May 15, 2026PARADIGM CAPITAL MANAGEMENT INC/NYSC 13G4,012,6985.2%Mar 31, 2026SEC filing
Mar 27, 2026The Vanguard GroupSC 13G/A00.0%Mar 13, 2026SEC filing
Feb 17, 2026Fuller & Thaler Asset Management, Inc.SC 13G/A3,636,359.964.7%Dec 31, 2025SEC filing
Nov 6, 2025Invesco Ltd.SC 13G/A3,490,9084.5%Sep 30, 2025SEC filing
Aug 5, 2025Morgan StanleySC 13G/A3,379,4014.3%Jun 30, 2025SEC filing
Jul 17, 2025BlackRock, Inc.SC 13G/A10,282,70513.2%Jun 30, 2025SEC filing
Jul 9, 2025Rubric Capital Management LPSC 13G/A7,353,9349.5%Jun 30, 2025SEC filing
May 14, 2025Rubric Capital Management LPSC 13G4,643,6726.0%Mar 31, 2025SEC filing

One filing is one row; a filing may list several reporters and the first is shown. Figures are as filed, including amendments that report zero shares after a transfer. Source: SEC Schedule 13D/G filings, 57,443 filings parsed to Oct 2, 2026.

Politician trading · U.S. Congress

Data unavailable — no congressional STOCK Act transactions for this ticker were parsed in the current window (as of Nov 16, 2026).

Government relations

Lobbying: 68 Lobbying Disclosure Act filings named this company as client, 1999–2026; most common issues: Medicare/Medicaid (41), Health Issues (22), Taxation/Internal Revenue Code (10).

Federal contracts: $1.6M in obligated amounts, fiscal years 2021–2026.

Fiscal yearObligated amount
FY2021$61.7K
FY2022$866.6K
FY2023$637.3K
FY2024$46.1K
FY2025$0
FY2026$0

Largest awards collected

Award IDAgencyAmountStart
36C24624P1850Department of Veterans Affairs$432.4KSep 6, 2024
75N90022P00543Department of Health and Human Services$418.8KSep 1, 2022
36C25622P1636Department of Veterans Affairs$372.6KSep 27, 2022
36C24625P1066Department of Veterans Affairs$369.1KMay 22, 2025
36C26223P1180Department of Veterans Affairs$249.5KApr 20, 2023

Lobbying filings are matched by company core name; a filing can match more than one ticker. Contract amounts are obligated amounts (money committed, not money spent), matched by recipient name — contracts under a subsidiary’s name can be missed. Sources: Senate Lobbying Disclosure Act filings; USAspending.gov. See Methodology.

Screens & lenses

Chart Signals

· Monthly Uptrend — Price above its 12-month moving average

Financial screens are computed from SEC company financial statements; red-flag models are screens, not verdicts — see Methodology.

Recent 8-K filings

FiledItemsSource
Oct 21, 20262.02 Results of Operations and Financial Condition · 9.01 Financial Statements and ExhibitsSEC filing
Oct 19, 20261.01 Entry into a Material Definitive Agreement · 1.02 Termination of a Material Definitive Agreement · 2.03 Creation of a Direct Financial Obligation · 7.01 Regulation FD Disclosure · 9.01 Financial Statements and ExhibitsSEC filing
Oct 9, 20267.01 Regulation FD Disclosure · 9.01 Financial Statements and ExhibitsSEC filing

Source: SEC EDGAR Form 8-K filings, latest first. Amendments (Form 8-K/A) are labeled as such. Item labels are the SEC's item titles; a filing can carry several items. Item 5.02 covers both departures and appointments, which this index does not distinguish.

Related

Stocks A–Z · Track Record: how the signals scored · Practice timing on IART

One email a week: the week’s new filings and research. Subscribe free

← IAG  ·  IAU →

Open the interactive tool →Live screens, charts and backtests for every tracked stock, fund and signal — free, no sign-up.